Vimarsana
Biggest News Aggregation in the World

Page 19 - Ar T News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ar T Today - Breaking & Trending Today

Global CAR-T Cell Therapy Market Report 2023: Remarkable - Vimarsana News

Global CAR-T Cell Therapy Market Report 2023: Remarkable

Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends, 2023" report has been...

Insights on the CAR T-Cell Therapy Global Market to 2031 - - Vimarsana News

Insights on the CAR T-Cell Therapy Global Market to 2031 -

Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "CAR T-Cell therapy Market By Drug type, By Indication, By End user: Global Opportunity Analysis and...

Drugmakers to Raise Prices on at Least 350 Drugs in US in January - Vimarsana News

Drugmakers to Raise Prices on at Least 350 Drugs in US in January

Drugmakers including Pfizer, GSK, BMS, AstraZeneca, and Sanofi plan to raise prices on more than 350 unique drugs in early January, according to data analyzed by a healthcare research firm.

Anti-cancer CAR-T therapy reengineers T cells to kill tumors – and researchers are expanding the limited types of cancer it can target - Vimarsana News

Anti-cancer CAR-T therapy reengineers T cells to kill tumors – and researchers are expanding the limited types of cancer it can target

Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.

High Response Rates With Talquetamab in Advanced Myeloma - Vimarsana News

High Response Rates With Talquetamab in Advanced Myeloma

The investigational, bispecific T-cell engager homes in on GPRC5D, a novel target unique to malignant plasma cells. It is awaiting approval from the Food and Drug Administration.